VALCHLOR® (mechlorethamine) gel is a prescription medicine used on the skin to treat people with Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) who have received previous skin treatment. It is not known if VALCHLOR is safe and effective in children.

The medicine for Stage IA/IB MF-CTCL that is CLEAR *

Artistic rendition of Stage IA/IB MF‑CTCL. Not an actual patient.

*In a clinical study, 119 VALCHLOR patients were evaluated over a 12-month period. 45.4% (54 out of 119 patients) experienced a partial response to the medication and 14.3% (17 out of 119 patients) achieved a complete response or clear skin in up to 5 index lesions. A complete response was achieved when the Composite Assessment of Index Lesion Severity (CAILS) score was 0, combining skin lesion ratings for redness, scaling, plaque elevation, and surface area.

VALCHLOR is a clear gel option to help patients with Stage IA/IB MF-CTCL.
Ask your doctor if VALCHLOR is right for you.